The future for GLP-1RA compounders, steps pharma can take in light of rising trial costs, funding ultra-rare therapies, and ...

The diabetes and weight loss drug semaglutide reversed liver scarring and inflammation. It’s among several drugs in the works for the condition MASH.

Does it seem like everyone from celebrities to your next-door neighbor is taking weight-loss drugs like Ozempic and Wegovy?

The US regulator has said that compounders can continue to trade in tirzepatide products while ... which is sold by Lilly as Mounjaro for diabetes and Zepbound for obesity, have actually been ...

The new move comes as Eli Lilly has also taken action against compounders making copies of tirzepatide, its GLP-1 and GIP agonist sold as Mounjaro for diabetes and Zepbound for obesity in the US.

Big pharmaceutical companies as well as smaller biotechs have been hoping to score a win in one of today's highest-growth ...

Many Medicaid enrollees with type 2 diabetes have restricted access to cardioprotective medications, including sod ...